Bioanalytical Method Validation Considerations for LC–MS/MS Assays of Therapeutic Proteins
- 25 June 2015
- journal article
- Published by Taylor & Francis in Bioanalysis
- Vol. 7 (11) , 1389-1395
Abstract
This paper highlights the recommendations of a group of industry scientists in validating regulated bioanalytical LC–MS/MS methods for protein therapeutics in a 2015 AAPSJ White Paper. This group recommends that most of the same precision and accuracy validation criteria used for ligand-binding assays (LBAs) be applied to LC–MS/MS-based assays where proteins are quantified using the LC–MS/MS signal from a surrogate peptide after proteolytic digestion (PrD-LCMS methods). PrD-LCMS methods are generally more complex than small molecule LC–MS/MS assays and may often include LBA procedures, leading to the recommendation for a combination of chromatographic and LBA validation strategies and appropriate acceptance criteria. Several key aspects of this bioanalytical approach that are discussed in the White Paper are treated here in additional detail. These topics include selectivity/specificity, matrix effect, digestion efficiency, stability and critical reagent considerations.Keywords
This publication has 8 references indexed in Scilit:
- Recommendations for Validation of LC-MS/MS Bioanalytical Methods for Protein BiotherapeuticsThe AAPS Journal, 2014
- Validation of LC–MS/MS Bioanalytical Methods for Protein TherapeuticsBioanalysis, 2014
- Ligand Binding Assay Critical Reagents and Their Stability: Recommendations and Best Practices from the Global Bioanalysis Consortium Harmonization TeamThe AAPS Journal, 2014
- LC–MS/MS of Large Molecules in A Regulated Bioanalytical Environment – Which Acceptance Criteria to Apply?Bioanalysis, 2013
- Replacing Immunoassays With Tryptic Digestion-Peptide Immunoaffinity Enrichment And Lc–MS/MSBioanalysis, 2012
- Absolute Quantitation of Protein Therapeutics in Biological Matrices by Enzymatic Digestion and LC–MSBioanalysis, 2011
- Bioanalytical Approaches to Analyzing Peptides and Proteins by LC–MS/MSBioanalysis, 2011
- Evaluation of Large Scale Quantitative Proteomic Assay Development Using Peptide Affinity-based Mass SpectrometryMolecular & Cellular Proteomics, 2011